Back to Selection     Print       Date : 28 Feb 2026
Fund Summary
ICICI Pru Pharma Healthcare And Diagnostics Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 13-Jul-18
Corpus(Cr.) 6801.0 Latest NAV 37.64 As on 18-03-2026
Equity(%) 97.98 52 Week High 41.47
Debt(%) 2.02 52 Week Low 34.39
Others(%) 0.0 Exit Load 1% for redemption within 15 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.86
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Dharmesh Kakkad
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 40.97%
Top 10 Holdings 61.24%
Top 25 Holdings 87.86%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 84.27
Healthcare 7.23
Retail 4.0
Cash 1.99
Miscellaneous 1.31
Chemicals 1.17
SOV 0.03
 
 
 
 
 
Portfolio Metrics
PB Ratio 3.68
PE Ratio 33.18
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 11.21
Cipla Limited 9.40
Mankind Pharma Limited 7.64
Dr Reddys Laboratories Limited 6.52
Biocon Limited 6.20
DIVI LABORATORIES LTD. 5.95
Lupin Limited 3.99
Aurobindo Pharma Limited 3.70
Alkem Laboratories Limited 3.47
Syngene International Limited 3.16
Cohance Lifesciences Limited 2.77
MedPlus Health Services Limited 2.54
TREPS 2.18
Alivus Life Sciences 2.11
Zydus Lifesciences Limited 2.07
AKUMS DRUGS & PHARMACEUTICALS LTD. 1.77
J B Chemicals and Pharma Ltd 1.75
Thyrocare Technologies Limited 1.75
ALEMBIC PHARMACEUTICALS 1.60
Gland Pharma Limited 1.54
Entero Healthcare Solutions 1.46
Pfizer Limited 1.34
Medi Assist Healthcare Services Limited 1.31
Blue Jet Healthcare Limited 1.22
Metropolis Healthcare Limited 1.21

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-0.79% -5.00% -8.24% 5.40%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
-7.40% -7.79% -6.22% 5.30%
 
Scheme Benchmark [NSE - Nifty Healthcare TRI]
-0.28% -0.38% -2.40% 7.86%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
12.54% 27.37% 17.77% 0.00%
 
 
5.06% 12.90% 11.60% 13.44%
 
 
11.44% 25.50% 16.54% 9.95%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
ICICI Pru Pharma Healthcare And Diagnostics Fund (G) 15.85% 1.4279 10.3854% 42.3545 0.1811
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
ICICI Pru Pharma Healthcare And Diagnostics Fund (G) 16.6708% 0.0002 0.3598 13.6655 1.1943
 
Back to Selection